Pharnext SCA
OTC:PNEXF

Watchlist Manager
Pharnext SCA Logo
Pharnext SCA
OTC:PNEXF
Watchlist
Price: 999 999.9999 USD
Market Cap: 6T USD
Have any thoughts about
Pharnext SCA?
Write Note

Wall Street
Price Targets

PNEXF Price Targets Summary
Pharnext SCA

There are no price targets for PNEXF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Pharnext SCA Competitors:
Price Targets
TGTX
TG Therapeutics Inc
11% Upside
096530
Seegene Inc
68% Upside
RCUS
Arcus Biosciences Inc
132% Upside
002252
Shanghai RAAS Blood Products Co Ltd
7% Downside
ARX
Aroa Biosurgery Ltd
45% Upside
1672
Ascletis Pharma Inc
15% Upside
VICO
Vicore Pharma Holding AB
281% Upside
CPRX
Catalyst Pharmaceuticals Inc
52% Upside

Revenue
Forecast

Revenue Estimate
Pharnext SCA

The compound annual growth rate of Pharnext SCA's revenue for the next 2 years is 12 731%.

N/A
Past Growth
12 731%
Estimated Growth
Estimates Accuracy
-95%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Pharnext SCA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Pharnext SCA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PNEXF's stock price target?
Not Available

PNEXF doesn't have any price targets made by Wall Street professionals.

What is Pharnext SCA's Revenue forecast?
Projected CAGR
12 731%

The compound annual growth rate of Pharnext SCA's revenue for the next 2 years is 12 731%.

Back to Top